Peer Review reports
From: Difference in drug cost between private and public drug plans in Quebec, Canada
| Original Submission | ||
|---|---|---|
| 2 Jun 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 14 Jul 2021 | Reviewed | Reviewer Report |
| 23 Jul 2021 | Reviewed | Reviewer Report |
| 29 Sep 2021 | Author responded | Author comments - Lucie Blais |
| Resubmission - Version 4 | ||
| 29 Sep 2021 | Submitted | Manuscript version 4 |
| 30 Sep 2021 | Author responded | Author comments - Lucie Blais |
| Resubmission - Version 5 | ||
| 30 Sep 2021 | Submitted | Manuscript version 5 |
| 7 Oct 2021 | Author responded | Author comments - Lucie Blais |
| Resubmission - Version 6 | ||
| 7 Oct 2021 | Submitted | Manuscript version 6 |
| 30 Oct 2021 | Author responded | Author comments - Lucie Blais |
| Resubmission - Version 7 | ||
| 30 Oct 2021 | Submitted | Manuscript version 7 |
| 2 Nov 2021 | Reviewed | Reviewer Report |
| 13 Nov 2021 | Reviewed | Reviewer Report |
| 20 Jan 2022 | Author responded | Author comments - Lucie Blais |
| Resubmission - Version 8 | ||
| 20 Jan 2022 | Submitted | Manuscript version 8 |
| Publishing | ||
| 3 Feb 2022 | Editorially accepted | |
| 14 Feb 2022 | Article published | 10.1186/s12913-022-07611-4 |
You can find further information about peer review here.